We’re glad to see you’re enjoying ReachMD…but how about a more personalized experience?
Expert Answers to Common Questions for Improving the Road to Remission with CAR T-Cell Therapies in Large B-Cell Lymphoma: Considerations for Community Practice
Caron A. Jacobson, MD
Targeting HER2 Across Advanced Solid Tumors
Susana Banerjee, MBBS, MA, FRCP, PhD
Brad McGregor, MD
Kathleen Moore, MD, MS, FASCO
Shubham Pant, MD, MBBS
Addressing the Unmet Need in HER2-Positive Advanced Solid Tumors: Exploring Response Rates and Duration of Response
Targeting HER2 in Advanced Solid Tumors: A Comprehensive Understanding of the Rationale and Potential Benefits
Testing for Solid Tumors: Tissue and Liquid Biopsy Approaches Using NGS Technologies for cfDNA and ctDNA Analysis
Management Strategies for Treatment-Emergent Adverse Events (TEAEs) in HER2-Altered Advanced Solid Tumors
Cervical Cancer: HER2-Targeted ADCs – Current Status and Future Directions
Ovarian Cancer: Advances in HER2-Targeted ADCs
Endometrial Cancer: HER2-Targeted ADCs: A Promising Approach to Address Unmet Needs
Biliary Tract and Pancreatic Cancer: HER2-Targeted ADCs for Gastrointestinal Cancers
Bladder Cancer: HER2-Targeted ADCs for Genitourinary Cancers
ASCO/ESMO 2023 Roundtable: Contextualizing the Latest Advances in HER2-Targeted Therapy for Solid Tumors
Advances in Minimally Invasive Screening for Lung Cancer: Breaking Data from Honolulu
Julie A. Barta, MD, ATSF
Peter J. Mazzone, MD, MPH, FCCP
Treatment Options for Invasive Fungal Infections: Why They Don't Always Work
Thomas F. Patterson, MD, FACP, FIDSA
George Thompson III, MD, FIDSA
Invasive Fungal Infections: More Common Than You Think
Peter G. Pappas, MD, FACP
Press cancel to remain on ReachMD. Press the link below or the continue button to keep going.
Stay current with the best on medical education